Abstract
Properties of delta-aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia were investigated with special reference to the protease in mitochondria of erythroblasts. delta-Aminolevulinic acid synthetase activity in erythroblasts of patients with this disease before treatment was extremely decreased, whereas it gradually increased in parallel with the improvement of anemia by the therapy with pyridoxal phosphate. The amount of apo-delta-aminolevulinic acid synthetase in erythroblasts before treatment was also extremely diminished. Apparent affinity to pyridoxal phosphate of the apo-delta-aminolevulinic acid synthetase obtained from erythroblasts of the patients was almost the same as that of normal controls. The activity of a new protease which is considered to be engaged in the regulation of delta-aminolevulinic acid synthetase levels in mitochondria of erythroblasts was shown to be in normal range in erythroblasts of the patients. On the other hand, apo-delta-aminolevulinic acid synthetase obtained from the patients was extremely sensitive to the protease. These results indicate that disturbance of heme synthesis characteristic to pyridoxine-responsive anemia could be ascribed to the hypercatabolism of delta-aminolevulinic acid synthetase caused by the increased susceptibility to the controlling protease in erythroblasts.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aoki Y. Crystallization and characterization of a new protease in mitochondria of bone marrow cells. J Biol Chem. 1978 Mar 25;253(6):2026–2032. [PubMed] [Google Scholar]
- Aoki Y., Urata G., Wada O., Takaku F. Measurement of delta-aminolevulinic acid synthetase activity in human erythroblasts. J Clin Invest. 1974 May;53(5):1326–1334. doi: 10.1172/JCI107680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cartwright G. E., Deiss A. Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J Med. 1975 Jan 23;292(4):185–193. doi: 10.1056/NEJM197501232920405. [DOI] [PubMed] [Google Scholar]
- Chatagner F., Durieu-Trautmann O. Effects of pyridoxine deficiency on the adaptation of rat liver cystathionase to DL-ethionine and to thyroidectomy. Nature. 1965 Sep 25;207(5004):1390–1391. doi: 10.1038/2071390a0. [DOI] [PubMed] [Google Scholar]
- Frimpter G. W. Cystathioninuria: nature of the defect. Science. 1965 Sep 3;149(3688):1095–1096. doi: 10.1126/science.149.3688.1095. [DOI] [PubMed] [Google Scholar]
- GAMMON G. C., BURGE F. W., KING G. Neural toxicity in tuberculous patients treated with isoniazid (isonicotinic acid hydrazide). AMA Arch Neurol Psychiatry. 1953 Jul;70(1):64–69. doi: 10.1001/archneurpsyc.1953.02320310070005. [DOI] [PubMed] [Google Scholar]
- GRANICK S., URATA G. Increase in activity of alpha-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3,5-dicarbethoxy-1,4-dihydrocollidine. J Biol Chem. 1963 Feb;238:821–827. [PubMed] [Google Scholar]
- GREENGARD O., GORDON M. THE COFACTOR-MEDIATED REGULATION OF APOENZYME LEVELS IN ANIMAL TISSUES. I. THE PYRIDOXINE-INDUCED RISE OF RAT LIVER TYROSINE TRANSAMINASE LEVEL IN VIVO. J Biol Chem. 1963 Nov;238:3708–3710. [PubMed] [Google Scholar]
- HARRIS J. W., HORRIGAN D. L. PYRIDOXINE-RESPONSIVE ANEMIA--PROTOTYPE AND VARIATIONS ON THE THEME. Vitam Horm. 1964;22:721–753. [PubMed] [Google Scholar]
- HARRIS J. W., WHITTINGTON R. M., WEISMAN R., Jr, HORRIGAN D. L. Pyridoxine responsive anemia in the human adult. Proc Soc Exp Biol Med. 1956 Mar;91(3):427–432. doi: 10.3181/00379727-91-22284. [DOI] [PubMed] [Google Scholar]
- Hines J. D., Grasso J. A. The sideroblastic anemias. Semin Hematol. 1970 Jan;7(1):86–106. [PubMed] [Google Scholar]
- Horrigan D. L., Harris J. W. Pyridoxine-responsive anemias in man. Vitam Horm. 1968;26:549–571. doi: 10.1016/s0083-6729(08)60774-8. [DOI] [PubMed] [Google Scholar]
- KIKUCHI G., KUMAR A., TALMAGE P., SHEMIN D. The enzymatic synthesis of delta-aminolevulinic acid. J Biol Chem. 1958 Nov;233(5):1214–1219. [PubMed] [Google Scholar]
- MUELLER J. F., VILTER R. W. Pyridoxine deficiency in human beings induced with desoxypyridoxine. J Clin Invest. 1950 Feb;29(2):193–201. doi: 10.1172/JCI102246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenberg L. E., Lilljeqvist A., Hsia Y. E. Methylmalonic aciduria: metabolic block localization and vitamin B 12 dependency. Science. 1968 Nov 15;162(3855):805–807. doi: 10.1126/science.162.3855.805. [DOI] [PubMed] [Google Scholar]
- SCRIVER C. R., HUTCHISON J. H. The vitamin B6 deficiency syndrome in human infancy: biochemical and clinical observations. Pediatrics. 1963 Feb;31:240–250. [PubMed] [Google Scholar]
- SNYDERMAN S. E., HOLT L. E., Jr, CARRETERO R., JACOBS K. Pyridoxine deficiency in the human infant. J Clin Nutr. 1953 Mar-Apr;1(3):200–207. doi: 10.1093/ajcn/1.3.200. [DOI] [PubMed] [Google Scholar]
- Tada K., Yokoyama Y., Nakagawa H., Yoshida T., Arakawa T. Vitamin B6 dependent xanthurenic aciduria. Tohoku J Exp Med. 1967 Oct;93(2):115–124. doi: 10.1620/tjem.93.115. [DOI] [PubMed] [Google Scholar]
- Umezawa H., Aoyagi T., Okura A., Morishima H., Takeuchi T. Letter: Elastatinal, a new elastase inhibitor produced by actinomycetes. J Antibiot (Tokyo) 1973 Dec;26(12):787–789. doi: 10.7164/antibiotics.26.787. [DOI] [PubMed] [Google Scholar]
- Weintraub L. R., Conrad M. E., Crosby W. H. Iron-loading anemia. Treatment with repeated phlebotomies and pyridoxine. N Engl J Med. 1966 Jul 28;275(4):169–176. doi: 10.1056/NEJM196607282750401. [DOI] [PubMed] [Google Scholar]
- Yoshida T., Tada K., Yokoyama Y., Arakawa T. Homocystinuria of vitamin B6 dependent type. Tohoku J Exp Med. 1968 Nov;96(3):235–242. doi: 10.1620/tjem.96.235. [DOI] [PubMed] [Google Scholar]
